In Vivo Requirement for Atg5 in Antigen Presentation by Dendritic Cells

Autophagy is known to be important in presentation of cytosolic antigens on MHC class II (MHC II). However, the role of autophagic process in antigen presentation in vivo is unclear. Mice with dendritic cell (DC)-conditional deletion in Atg5, a key autophagy gene, showed impaired CD4 + T cell primin...

Full description

Saved in:
Bibliographic Details
Published in:Immunity (Cambridge, Mass.) Vol. 32; no. 2; pp. 227 - 239
Main Authors: Lee, Heung Kyu, Mattei, Lisa M., Steinberg, Benjamin E., Alberts, Philipp, Lee, Yun Hee, Chervonsky, Alexander, Mizushima, Noboru, Grinstein, Sergio, Iwasaki, Akiko
Format: Journal Article
Language:English
Published: United States Elsevier Inc 26-02-2010
Elsevier Limited
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Autophagy is known to be important in presentation of cytosolic antigens on MHC class II (MHC II). However, the role of autophagic process in antigen presentation in vivo is unclear. Mice with dendritic cell (DC)-conditional deletion in Atg5, a key autophagy gene, showed impaired CD4 + T cell priming after herpes simplex virus infection and succumbed to rapid disease. The most pronounced defect of Atg5 −/− DCs was the processing and presentation of phagocytosed antigens containing Toll-like receptor stimuli for MHC class II. In contrast, cross-presentation of peptides on MHC I was intact in the absence of Atg5. Although induction of metabolic autophagy did not enhance MHC II presentation, autophagic machinery was required for optimal phagosome-to-lysosome fusion and subsequent processing of antigen for MHC II loading. Thus, our study revealed that DCs utilize autophagic machinery to optimally process and present extracellular microbial antigens for MHC II presentation. ► DCs use autophagy machinery to process exogenous microbial antigens for MHC II ► Canonical autophagy is not required for processing of phagocytosed antigens ► Mice with Atg5 deletion in DCs fail to induce Th1 cells and succumb to HSV infection
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
Present address: Program in Cell Biology, Hospital for Sick Children, Toronto, Ontario, Canada
Present address: Department of Radiation Oncology, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea
Present address: Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 305-701, Republic of Korea
ISSN:1074-7613
1097-4180
DOI:10.1016/j.immuni.2009.12.006